Lots of considerations when evaluating the FujiLAM assay.

Garcia-Basteiro AL, Cobelens F, Ssengooba W, Theron G.

DOI: 10.1016/s2214-109x(23)00114-6
Published: 2023-04-01
Container: Lancet Glob Health
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2214-109x-23-00114-6,
  title = {Lots of considerations when evaluating the FujiLAM assay.},
  author = {Garcia-Basteiro AL and  Cobelens F and  Ssengooba W and  Theron G.},
  year = {2023},
  journal = {Lancet Glob Health},
  doi = {10.1016/s2214-109x(23)00114-6},
  url = {https://doi.org/10.1016/s2214-109x(23)00114-6}
}

RIS

TY  - JOUR
TI  - Lots of considerations when evaluating the FujiLAM assay.
AU  - Garcia-Basteiro AL
AU  -  Cobelens F
AU  -  Ssengooba W
AU  -  Theron G.
PY  - 2023
JO  - Lancet Glob Health
DO  - 10.1016/s2214-109x(23)00114-6
UR  - https://doi.org/10.1016/s2214-109x(23)00114-6
ER  -

APA

AL, G., F, C., W, S., & G., T. (2023). Lots of considerations when evaluating the FujiLAM assay.. Lancet Glob Health. https://doi.org/10.1016/s2214-109x(23)00114-6

Source records

europe-pmc · retrieved 2026-09-26T20:06:54.994Z
hal · retrieved 2026-09-26T20:06:55.010Z